ESP Block in VATS: Programmed Intermittent Bolus Versus Continuous Infusion on Quality of Recovery
Pain, Acute, Surgery
About this trial
This is an interventional treatment trial for Pain, Acute focused on measuring Regional Anesthesia, Erector Spinae Block, VATS, Quality of Recovery, Acute pain
Eligibility Criteria
Inclusion Criteria:
- Male and Female aged > 18
- Able to provide written informed consent
- ASA grade I - V
- VATS surgery
- Weight > 55kg
Exclusion Criteria:
- Absence of or inability to give informed consent
- Pre-existing infection at block site
- Severe coagulopathy
- Allergy to local anaesthesia (or another contraindication to block performance)
- Previous history of opiate abuse
- Pre-existing chronic pain condition
- Pre-existing dementia (due to need to co-operate in completing QoR-15 score day after surgery
- Postoperative admission to ICU for continued ventilation
- BMI > 40 kg/m2
Sites / Locations
- Mater Misericordiae University Hospital
- St Jame's University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB)
Ultrasound Guided ESP Block with Continuous Infusion (CI)
After induction of general anaesthesia, an ESP catheter will be inserted at the level of T5. A bolus dose of 20 ml 0.25% Levobupicaine will be administered into the ESP space. Two hours post bolus administration, patients will receive programmed intermittent bolus of local anaesthetic: 20mls 0.125% levobupivacaine every two hours.
After induction of general anaesthesia, an ESP catheter will be inserted at the level of T5. A bolus dose of 20 ml 0.25% Levobupicaine will be administered into the ESP space. Two hours post bolus administration, patients will receive a continuous infusion local anaesthetic: 0.125% levobupivacaine at an infusion rate of 10 ml/hr.